BioSpace News Archive

There are many more shots on cancer this week as funding went to oncology-focused companies such as GluBio and Shanghai-based OriCell.

Alnylam revealed its Phase III APOLLO-B study, which showed that patisiran improves both functional capacity and quality of life in patients with ATTR amyloidosis with cardiomyopathy.

Wilmington, Delaware, United States, Transparency Market Research Inc.: The global drug discovery outsourcing market was valued at ~US$ 4.5 Bn in 2019.

Wilmington, Delaware, United States, Transparency Market Research Inc.: The global centrifuge market was valued at ~US$ 1 Bn in 2019 and is projected to expand at a considerable CAGR from 2020 to 2030.

Surge in advancements in healthcare infrastructure has boosted investments in medical education.

Ipsen announced that the Phase III RESILIENT trial did not meet its primary endpoint of overall survival compared to topotecan.

Burning Rock Biotech Limited, a company focusing on the application of next generation sequencing technology in the field of precision oncology, announced that it will hold its annual general meeting on September 8, 2022 at 10:00 a.m. at the Company’s Shanghai office at 5/F, Building 1, No. 138 Xinjunhuan Road, Minhang District, Shanghai.

Castle Biosciences, Inc. today announced that Derek Maetzold, president and chief executive officer, and Frank Stokes, chief financial officer, are scheduled to present a company overview at the Canaccord Genuity 42 nd Annual Growth Conference on Wednesday, Aug. 10, 2022, at 1:00 p.m. Eastern time.

Seres Therapeutics, Inc. today reported second quarter 2022 financial results and provided business updates.

Channel Medsystems, Inc., a medical device company whose mission is to empower every woman to take control of her health journey, announced that Heather Knight has joined the company’s Board of Directors.